Kamada (KMDA) Goodwill & Intangibles (2020 - 2026)
Kamada (KMDA) posted quarterly Goodwill & Intangibles of $126.0 million for Q1 2026, down 4.36% year-on-year from $131.7 million in Q1 2025, and down 1.44% on a QoQ basis from $127.8 million in Q4 2025.
Kamada (KMDA) Goodwill & Intangibles (2020 - 2026) Analysis & Trends
Kamada (KMDA) has reported Goodwill & Intangibles for 7 consecutive years, with $126.0 million the latest figure, recorded in Q1 2026.
- Quarterly Goodwill & Intangibles fell 4.36% year-over-year to $126.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $126.0 million (down 4.36% YoY) and the FY2025 annual result came in at $127.8 million, up 23.83% from the prior year.
- Goodwill & Intangibles eased to $126.0 million in Q1 2026 per KMDA's latest filing, from $127.8 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for KMDA reached as high as $151.9 million in Q1 2022 and fell as low as $138623.0 in Q1 2024.
- A 5-year average of $108.0 million and a median of $129.5 million in 2025 frame the typical range for Goodwill & Intangibles.
- The largest YoY upside for Goodwill & Intangibles was 95782.79% in 2023 against a maximum downside of 99.9% in 2023.
- Year by year, Goodwill & Intangibles stood at $147.1 million in 2022, then declined by 4.49% to $140.5 million in 2023, then decreased by 26.51% to $103.2 million in 2024, then grew by 23.83% to $127.8 million in 2025, then fell by 1.44% to $126.0 million in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $126.0 million, $127.8 million, and $129.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125.99 Mn |
| Dec 31, 2025 | 127.82 Mn |
| Sep 30, 2025 | 129.50 Mn |
| Jun 30, 2025 | 99.64 Mn |
| Mar 31, 2025 | 131.74 Mn |
| Dec 31, 2024 | 103.23 Mn |
| Sep 30, 2024 | 135.04 Mn |
| Jun 30, 2024 | 106.52 Mn |
| Mar 31, 2024 | 138,623.00 |
| Dec 31, 2023 | 140.47 Mn |
| Sep 30, 2023 | 142.50 Mn |
| Jun 30, 2023 | 143.99 Mn |
| Mar 31, 2023 | 145,305.00 |
| Dec 31, 2022 | 147.07 Mn |
| Sep 30, 2022 | 148,620.00 |
| Jun 30, 2022 | 150.45 Mn |
| Mar 31, 2022 | 151.86 Mn |
| Dec 31, 2021 | 153.66 Mn |
| Sep 30, 2021 | 3.38 Mn |
| Jun 30, 2021 | 3.41 Mn |